Inventor · disambiguated record
Carlo Farina
Also filed as: FARINA CARLO · PIFFERI GIORGIO
36 granted patents·34 pending applications·340 citations·filing 1978–2020
97Inventor score
Files withISF SPA13SMITHKLINE BEECHAM SPA9GLAXOSMITHKLINE SPA6FARINA CARLO5Metys Pharmaceuticals AG4
Top patents by PatentIndex Score
70 records- 0190US5811553AQuinoline derivatives(2)SMITHKLINE BEECHAM FARMA·Filed 1995·Granted Sep 22, 1998·68 cites·2 claims
- 0287US7482458B2Quinoline derivativesSMITHKLINE BEECHAM FARMA·Filed 2006·Granted Jan 27, 2009·8 cites·1 claims
- 0381US7544705B2Pyrroloimidazole derivatives, their preparation, pharmaceutical composition containing them, and their use as nootropic agentsNEUROTUNE AG·Filed 2004·Granted Jun 9, 2009·18 cites·16 claims
- 0481US6743804B2Quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2002·Granted Jun 1, 2004·11 cites·1 claims
- 0578US6277862B1Quinoline derivativesSMITHKLINE BEECHAM SPA·Filed 1996·Granted Aug 21, 2001·47 cites·29 claims
- 0677US7732473B2Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereofNEUROTUNE AG·Filed 2009·Granted Jun 8, 2010·3 cites·8 claims
- 0777US6787550B1Indole derivatives and their use for the treatment of osteoporosis amongst other applicationsNIKEM RESEARCH SRL·Filed 2000·Granted Sep 7, 2004·14 cites·22 claims
- 0875US4173648A3β-Hydroxy-18β-olean-9-en-30-oic acidsISF SPA·Filed 1978·Granted Nov 6, 1979·12 cites·11 claims
- 0974US6432977B1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2001·Granted Aug 13, 2002·8 cites·3 claims
- 1072US6903117B2Indole derivatives for the treatment of osteoporosisNIKEM RESEARCH SRL·Filed 2002·Granted Jun 7, 2005·6 cites·4 claims
- 1172US6780875B2Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonistsSMITHKLINE BEECHAM SPA·Filed 2003·Granted Aug 24, 2004·6 cites·6 claims
- 1271US6025390AHeteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorptionSMITHKLINE BEECHAM SPA·Filed 1997·Granted Feb 15, 2000·15 cites·10 claims
- 1370US6608083B1Quinoline derivatives(2)SMITHKLINE BEECHAM FARMA·Filed 1995·Granted Aug 19, 2003·21 cites·54 claims
- 1469US7220769B2Azolylbenzamides and analogues and their use for treating osteoporosisNIKEM RESEARCH SRL·Filed 2004·Granted May 22, 2007·6 cites·8 claims
- 1568US7973066B2Pyrrolo[1,2-A]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agentsNEUROTUNE AG·Filed 2007·Granted Jul 5, 2011·1 cites·9 claims
- 1666US5053422APsychotropic perhydroazacycloalka [1,2-A] imidazole derivativesISF SPA·Filed 1989·Granted Oct 1, 1991·11 cites·22 claims
- 1764US8222241B2Use of dimiracetam in the treatment of chronic painFARINA CARLO·Filed 2011·Granted Jul 17, 2012·1 cites·11 claims
- 1864US5981525AIndole derivatives useful in the treatment of osteoporosisSMITHKLINE BEECHAM CORP·Filed 1996·Granted Nov 9, 1999·24 cites·13 claims
- 1963US4575552AProcess of making ethyl[6-[ethyl-(2-hydroxypropyl)amino]-3-pyridazinyl]hydrazine carboxylateISF SPA·Filed 1984·Granted Mar 11, 1986·4 cites·5 claims
- 2062US4530934APharmaceutically active ursolic acid derivativeISF SPA·Filed 1983·Granted Jul 23, 1985·7 cites·5 claims
- 2161US2007259882A13-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonistsGLAXOSMITHKLINE SPA·Filed 2007·Application pending·0 cites
- 2260US9125898B2Acetam derivatives for pain reliefFARINA CARLO·Filed 2009·Granted Sep 8, 2015·0 cites·10 claims
- 2360US2007161647A1QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTSGLAXOSMITHKLINE SPA·Filed 2007·Application pending·0 cites
- 2460US2005096316A1Quinoline derivatives(2)Filed 2004·Application pending·0 cites
- 2559US6355654B1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 1996·Granted Mar 12, 2002·11 cites·6 claims
- 2658US2006229315A13-Substituted Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor AntagonistsGLAXOSMITHKLINE SPA·Filed 2006·Application pending·0 cites
- 2757US7989421B2Use of dimiracetam in the treatment of chronic painNEUROTUNE AG·Filed 2008·Granted Aug 2, 2011·0 cites·4 claims
- 2856US10738054B2Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2018·Granted Aug 11, 2020·0 cites·23 claims
- 2956US2005070574A1Novel compoundsGLAXOSMITHKLINE SPA AND LABORA·Filed 2004·Application pending·0 cites
- 3055US5200406APharmaceutically useful 2,5-dioxo-1H-octahydroimidazo[1,2-A]azepinesISF SPA·Filed 1992·Granted Apr 6, 1993·5 cites·8 claims
- 3155US2005176762A1Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonistsGLAXOSMITHKLINE SPA·Filed 2005·Application pending·0 cites
- 3255US2006161004A1Novel compoundsGLAXOSMITHKLINE LAB SAS·Filed 2006·Application pending·0 cites
- 3354US2020331919A1Synergistic compositions comprising (R)-dimiracetam (1) and (S)-dimiracetam (2) in a non-racemic ratioMetys Pharmaceuticals AG·Filed 2020·Application pending·0 cites
- 3453US4824861APyrrolidone derivatives and memory enhancement use thereofISF SPA·Filed 1987·Granted Apr 25, 1989·6 cites·4 claims
- 3552US2006235026A1Quinoline-4-Carboxamide Derivatives as NK-3 and NK-2 Receptor AntagonistsGLAXOSMITHKLINE S A S·Filed 2006·Application pending·0 cites
- 3651US2007015766A1Quinoline Derivatives as NK-3 and NK-2 AntagonistsGLAXOSMITHKLINE S A S·Filed 2006·Application pending·0 cites
- 3751US2004152726A1Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonistsFiled 2002·Application pending·0 cites
- 3851US2003236281A1Quinoline derivatives(2)Filed 2001·Application pending·0 cites
- 3950US5130319APharmacologically active 2,5-dioxo-octahydro-imidazo [1,2-a]pyridinesISF SPA·Filed 1991·Granted Jul 14, 1992·7 cites·8 claims
- 4050US2002156097A1Salts of quinoline derivatives as NK3 antagonistsSMITHKLINE BEECHAM SPA·Filed 2002·Application pending·0 cites
- 4149US2004102633A1Novel compoundsFiled 2001·Application pending·0 cites
- 4248US2004235930A1Indole derivatives and their use for the treatment of osteoporosis amongst other applicationsFiled 2004·Application pending·0 cites
- 4346US2002173659A1Indole derivatives for the treatment of osteoporosisSMITH KLINE BEECHAM SPA·Filed 2001·Application pending·0 cites
- 4444US6613770B1Quinoline derivatives as NK-2 and NK-3 receptor ligandsSMITHKLINE BEECHAM SPA·Filed 1999·Granted Sep 2, 2003·5 cites·10 claims
- 4544US2004077658A1Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonistsFiled 2001·Application pending·0 cites
- 4644US2004082589A1Quinoline derivatives as nk-3 and nk-2 antagonistsFiled 2001·Application pending·0 cites
- 4744US2005182093A1Novel compoundsGLAXOSMITHKLINE SPA·Filed 2005·Application pending·0 cites
- 4843US2010173945A1Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereofFARINA CARLO·Filed 2010·Application pending·0 cites
- 4943US2006223819A1Quinoline Derivatives as NK-3 AntagonistsGLAXOSMITHKLINE SPA·Filed 2006·Application pending·0 cites
- 5043US2022047548A1SYNERGISTIC COMPOSITIONS COMPRISING (R)-2-(2-OXOPYRROLIDIN-1-YL)BUTANAMIDE AND (S)-2-(2-e OXOPYRROLEDIN-1-YL)BUTANAMEDE IN A NON-RACEMIC RATIOMetys Pharmaceuticals AG·Filed 2019·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Carlo Farina files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →